Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
The Doshisha holds 112 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 112 |
| Recent patents | 29 |
| First publication | Sep 15, 2016 |
| Latest publication | Mar 12, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026070921-A1 · Mar 12, 2026 · US
US-2026074205-A1 · Mar 12, 2026 · US
US-2026035804-A1 · Feb 5, 2026 · US
US-2026035826-A1 · Feb 5, 2026 · US
US-2025369129-A1 · Dec 4, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026070921-A1 · Mar 12, 2026 · US
US-2026074205-A1 · Mar 12, 2026 · US
US-2026035804-A1 · Feb 5, 2026 · US
US-2026035826-A1 · Feb 5, 2026 · US
US-2025369129-A1 · Dec 4, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 47 |
| Chemistry & Metallurgy | 45 |
| Electricity | 30 |
| Physics | 23 |
| Cross-Sectional Technologies | 18 |
| Operations & Transport | 12 |
| Mechanical Engineering | 5 |
Answers are generated from the same data shown on this page.